Hyperoside Attenuates Bleomycin-Induced Pulmonary Fibrosis Development in Mice

Hyperoside Attenuates Bleomycin-Induced Pulmonary Fibrosis Development in Mice

Idiopathic pulmonary fibrosis (IPF) is a progressive, lethal, and chronic lung disease. There are no effective drug therapies for IPF. Hyperoside, a flavonoid glycoside, has been proven to have anti-inflammatory, anti-fibrosis, antioxidant, and anti-cancer effects. The aim of this study was to explo...

Full description

Bibliographic Details
Main Authors:	Jizhen Huang, Xiang Tong, Li Zhang, Yuan Zhang, Lei Wang, Dongguang Wang, Shijie Zhang, Hong Fan
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-10-01
Series:	Frontiers in Pharmacology
Subjects:	hyperoside pulmonary fibrosis epithelial-mesenchymal transition oxidative stress inflammation
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2020.550955/full

Similar Items

Osteopontin silencing attenuates bleomycin-induced murine pulmonary fibrosis by regulating epithelial–mesenchymal transition
by: Omer Faruk Hatipoglu, et al.
Published: (2021-07-01)

Mefunidone Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Mice
by: Yuanyuan Han, et al.
Published: (2021-09-01)

Antifibrotic Mechanism of Cinobufagin in Bleomycin-Induced Pulmonary Fibrosis in Mice
by: Xiaohe Li, et al.
Published: (2019-09-01)

Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling
by: Demin Cheng, et al.
Published: (2021-08-01)

Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition
by: Sun Young Kyung, et al.
Published: (2018-04-01)

Deglycosylated Azithromycin Attenuates Bleomycin-Induced Pulmonary Fibrosis via the TGF-β1 Signaling Pathway
by: Hao Ruan, et al.
Published: (2021-05-01)

GHK Peptide Inhibits Bleomycin-Induced Pulmonary Fibrosis in Mice by Suppressing TGFβ1/Smad-Mediated Epithelial-to-Mesenchymal Transition
by: Xiao-Ming Zhou, et al.
Published: (2017-12-01)

Vitamin D deficiency exacerbates bleomycin-induced pulmonary fibrosis partially through aggravating TGF-β/Smad2/3-mediated epithelial-mesenchymal transition
by: Se-Ruo Li, et al.
Published: (2019-11-01)

Tauroursodeoxycholic acid alleviates pulmonary endoplasmic reticulum stress and epithelial-mesenchymal transition in bleomycin-induced lung fibrosis
by: Bin Tong, et al.
Published: (2021-05-01)

Kurarinone Attenuates BLM-Induced Pulmonary Fibrosis via Inhibiting TGF-β Signaling Pathways
by: Soo-Jin Park, et al.
Published: (2021-08-01)

Mushroom Inonotus sanghuang alleviates experimental pulmonary fibrosis: Implications for therapy of pulmonary fibrosis
by: Xing Su, et al.
Published: (2021-01-01)

Hyperoside attenuates dextran sulfate sodium-induced colitis in mice possibly via activation of the Nrf2 signalling pathway
by: Lei Yang, et al.
Published: (2017-11-01)

Fisetin Alleviated Bleomycin-Induced Pulmonary Fibrosis Partly by Rescuing Alveolar Epithelial Cells From Senescence
by: Li Zhang, et al.
Published: (2020-12-01)

Antitumor Effect of Hyperoside Loaded in Charge Reversed and Mitochondria-Targeted Liposomes
by: Feng Y, et al.
Published: (2021-04-01)

Epithelial–Mesenchymal Transition in the Pathogenesis of Idiopathic Pulmonary Fibrosis
by: Francesco Salton, et al.
Published: (2019-03-01)

Src family kinases and pulmonary fibrosis: A review
by: Hang Li, et al.
Published: (2020-07-01)

Pterostilbene alleviates pulmonary fibrosis by regulating ASIC2
by: Yanfang Peng, et al.
Published: (2021-07-01)

Ginsenoside Rg3 inhibits pulmonary fibrosis by preventing HIF-1α nuclear localisation
by: Zhuo Fu, et al.
Published: (2021-02-01)

Hyperoside Protects Against Pressure Overload-Induced Cardiac Remodeling via the AKT Signaling Pathway
by: Xiaofang Wang, et al.
Published: (2018-11-01)

Therapeutic Potential of Exosomes in Pulmonary Fibrosis
by: Linshen Xie, et al.
Published: (2020-12-01)

Induced pluripotent stem cells inhibit bleomycin-induced pulmonary fibrosis in mice through suppressing TGF-β1/Smad-mediated epithelial to mesenchymal transition
by: Yan Zhou, et al.
Published: (2016-11-01)

An Adaptogen: Withaferin A Ameliorates in Vitro and in Vivo Pulmonary Fibrosis by Modulating the Interplay of Fibrotic, Matricelluar Proteins, and Cytokines
by: Swarna Bale, et al.
Published: (2018-03-01)

The antioxidant N-acetylcysteine promotes immune response and inhibits epithelial-mesenchymal transition to alleviate pulmonary fibrosis in chronic obstructive pulmonary disease by suppressing the VWF/p38 MAPK axis
by: Lanlan Zhu, et al.
Published: (2021-09-01)

Human umbilical cord mesenchymal stem cell-derived exosomal miR-27b attenuates subretinal fibrosis via suppressing epithelial–mesenchymal transition by targeting HOXC6
by: Dongli Li, et al.
Published: (2021-01-01)

Arctigenin Suppressed Epithelial-Mesenchymal Transition Through Wnt3a/β-Catenin Pathway in PQ-Induced Pulmonary Fibrosis
by: Fei Gao, et al.
Published: (2020-12-01)

Catalpol Protects Against Pulmonary Fibrosis Through Inhibiting TGF-β1/Smad3 and Wnt/β-Catenin Signaling Pathways
by: Fan Yang, et al.
Published: (2021-01-01)

Differences in epithelial-mesenchymal-transition in paraquat-induced pulmonary fibrosis in BALB/C and BALB/C (nu/nu) nude mice
by: Yegang Hu, et al.
Published: (2021-11-01)

Hyperoside ameliorates periodontitis in rats by promoting osteogenic differentiation of BMSCs via activation of the NF‐κB pathway
by: Tao Xu, et al.
Published: (2020-09-01)

Development and application of a rapid HPLC method for simultaneous determination of hyperoside, isoquercitrin and eleutheroside E in Apocynum venetum L. and Eleutherococcus senticosus
by: Jie Shen, et al.
Published: (2020-05-01)

Role of CXCL16 in BLM-induced epithelial–mesenchymal transition in human A549 cells
by: Zhenzhen Ma, et al.
Published: (2021-02-01)

The Effects of Silymarin in Bleomycin-Induced Pulmonary Fibrosis in Mice
by: L. Safaeian, et al.
Published: (2009-08-01)

The Effects of Silymarin in Bleomycin-Induced Pulmonary Fibrosis in Mice
by: Safaeian, et al.
Published: (2009-06-01)

Hyperoside prevents sepsis-associated cardiac dysfunction through regulating cardiomyocyte viability and inflammation via inhibiting miR-21
by: Jun Zhang, et al.
Published: (2021-06-01)

Hyperoside ameliorates diabetic nephropathy induced by STZ via targeting the miR-499–5p/APC axis
by: Jingbo Zhou, et al.
Published: (2021-05-01)

Effect of hyperoside on cervical cancer cells and transcriptome analysis of differentially expressed genes
by: Weikang Guo, et al.
Published: (2019-09-01)

New Insights Into the Role and Mechanism of Partial Epithelial-Mesenchymal Transition in Kidney Fibrosis
by: Lili Sheng, et al.
Published: (2020-09-01)

Hyperoside Downregulates the Receptor for Advanced Glycation End Products (RAGE) and Promotes Proliferation in ECV304 Cells via the c-Jun N-Terminal Kinases (JNK) Pathway Following Stimulation by Advanced Glycation End-Products In Vitro
by: Zhengyu Zhang, et al.
Published: (2013-11-01)

Icariin attenuates bleomycin-induced pulmonary fibrosis by targeting Hippo/YAP pathway
by: Wenjing Du, et al.
Published: (2021-11-01)

Research progress in EMT and fibrosis of hepatobiliary system
by: ZENG Shuaidan
Published: (2014-07-01)

Transcriptomic profiling reveals disease-specific characteristics of epithelial cells in idiopathic pulmonary fibrosis
by: Maximilian Boesch, et al.
Published: (2020-06-01)

Cannot write session to /tmp/vufind_sessions/sess_1imgr3tdkvughosh1oh0q0bl5q